NasdaqCM - Delayed Quote USD

NeuroOne Medical Technologies Corporation (NMTC)

0.5574
-0.0355
(-5.99%)
At close: 4:00:00 PM EDT
0.5598
+0.00
+(0.43%)
After hours: 5:40:56 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. David A. Rosa M.D. President, CEO & Director 750.17k -- 1964
Mr. Ronald W. McClurg Chief Financial Officer 386.06k -- 1960
Mr. Christopher R. Volker CFA Chief Operating Officer 377.11k -- --
Mr. Mark Christianson Co-Founder, Business Development Director & Medical Sales Liaison 260.85k -- 1967
Mr. Steven Mertens Chief Technology Officer 332.26k -- 1963
Mr. Hijaz Haris Vice President of Marketing -- -- --
Dr. Parag G. Patil M.D., Ph.D. Chief Medical Advisor -- -- --

NeuroOne Medical Technologies Corporation

7599 Anagram Drive
Eden Prairie, MN 55344
United States
952 426 1383 https://nmtc1.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
17

Description

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.

Corporate Governance

NeuroOne Medical Technologies Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 12, 2025 at 10:59 AM UTC - August 18, 2025 at 12:00 PM UTC

NeuroOne Medical Technologies Corporation Earnings Date

Recent Events

May 13, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 9, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 7, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 20, 2025 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

February 14, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 12, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

February 7, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

February 5, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

February 4, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 21, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

Related Tickers